Human Longevity, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Human Longevity, Inc. - overview

Established

2013

Location

San Diego, CA, US

Primary Industry

Biotechnology

About

Founded in 2013 by founder J. Craig Venter and based in California, US, Human Longevity, Inc. provides a clinical research platform that compiles and analyzes genotypic and phenotypic data to understand and generate insights that will help to accelerate ways to discover and prevent risks and signals of diseases. In August 2024, Human Longevity, Inc.


raised USD 21. 5 million in Series B funding. The Series B funding values Human Longevity, Inc. at USD 173.


26 million post-money. Human Longevity, Inc. v offers genome sequencing to analyze an individual’s genetic makeup. This information helps in assessing genetic risk factors and guiding personalized health recommendations.


The company conducts detailed health evaluations that include diagnostic tests to identify potential health issues and develop personalized health management plans. The diagnostic tests include coronary calcium scoring, advanced blood tests, echocardiograms, electrocardiograms, exercise stress tests, and insulin sensitivity testing. These tests help in assessing cardiovascular health, metabolic function, and other health parameters. Additionally, the firm uses wearable technology to track daily health metrics, such as glucose levels and sleep patterns.


This continuous monitoring helps refine health recommendations and interventions.


Current Investors

Draper Fisher Jurvetson, BB Retail Capital, Genting Berhad

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Bioinformatics, Healthcare IT, Analytics & Performance Software

Website

www.humanlongevity.com

Verticals

Artificial Intelligence, HealthTech, Wearables & Quantified Self

Total Amount Raised

Subscriber access only

Human Longevity, Inc. - key contacts

NamePositionStart DateEnd DateVcardBio 
Member Board Of DirectorsBM

BM Board Member

Want to see more?

Request a demo for full access to this profile

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.